Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.363 | 0.749 | 1.00000 | 1.00000 | |
RegionR2 | 2.524 | 0.749 | 0.99937 | 1.00000 | |
RegionR3 | -0.662 | 0.749 | 1.00000 | 1.00000 | |
RegionR4 | 0.695 | 0.749 | 0.99960 | 1.00000 | |
RegionR5 | -0.171 | 0.749 | 1.00000 | 1.00000 | |
RegionR6 | -0.709 | 0.749 | 1.00000 | 1.00000 | |
RegionR7 | -0.796 | 0.749 | 1.00000 | 1.00000 | |
RegionR8 | -0.519 | 0.749 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.547 | 0.749 | 1.00000 | 1.00000 | |
RegenerationR2 | 0.373 | 0.749 | 0.67311 | 0.94643 | |
RegenerationR3 | 1.555 | 0.749 | 0.98143 | 1.00000 | |
RegenerationR4 | -0.173 | 0.749 | 0.99798 | 1.00000 | |
RegenerationR5 | -0.594 | 0.749 | 0.99544 | 1.00000 | |
RegenerationR6 | -0.753 | 0.749 | 0.99971 | 1.00000 | |
RegenerationBL | -0.678 | 0.749 | 0.99978 | 1.00000 | |
RegenerationTP | -0.67 | 0.749 | 0.99989 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
2. | MligTC455_05753 | 20 | 0.43 | Mlig455_046443, Mlig455_046475 | Neo: - Age: - |
3.743 | - | - | 0.910 | 0.898 | 0.953 | 0.982 | Mlig455_046443 {REF} {Length: 1972} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=89.6]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.0]; Taste receptor protein (TAS2R) [PF05296.15, score=25.1]} {Dmel: FBgn0264002, MsR2, Myosuppressin receptor 2, [Score=86.3, Expect=8e-18]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=84.7, Expect=1e-17]} {Smed: dd_Smed_v6_17590_0_1, dd_Smed_v6_17590_0_1, [Score=141, Expect=9e-38]} {RNA1310_111897} Mlig455_046475 {REF} {Length: 1474} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=90.2]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=46.5]; Taste receptor protein (TAS2R) [PF05296.15, score=24.9]} {Dmel: FBgn0264002, MsR2, Myosuppressin receptor 2, [Score=86.7, Expect=7e-18]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=85.5, Expect=7e-18]} {Smed: dd_Smed_v6_17590_0_1, dd_Smed_v6_17590_0_1, [Score=142, Expect=1e-37]} {RNA1310_111897} |
|
3. | MligTC455_16781 | 32 | 0.67 | Mlig455_003020, Mlig455_003313 | Neo: - Age: - |
3.681 | - | - | 0.940 | 0.764 | 0.995 | 0.982 | Mlig455_003020 {REF} {Length: 518} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=26.8]} {RNA1310_57787} {RNA815_49158} Mlig455_003313 {REF} {Length: 905} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=74.4]} {RNA1310_57787} {RNA815_49158} |
|
4. | MligTC455_18990 | 13 | 0.28 | Mlig455_069976 | Neo: - Age: - |
SYN1 | 3.654 | - | - | 0.997 | 0.914 | 0.891 | 0.852 | Mlig455_069976 {REF} {Length: 2476} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=235.0]; Synapsin, N-terminal domain [PF02078.18, score=137.7]} {Human: ENSG00000008056, SYN1, synapsin I, [RH, Score=324, Expect=2e-102]; ENSG00000157152, SYN2, synapsin II, [RH, Score=324, Expect=2e-103]; ENSG00000185666, SYN3, synapsin III, [RH, Score=322, Expect=9e-103]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [RH, Score=327, Expect=5e-105]; ENSMUSG00000037217, Syn1, synapsin I, [RH, Score=324, Expect=9e-103]; ENSMUSG00000009394, Syn2, synapsin II, [RH, Score=323, Expect=9e-105]} {Dmel: FBgn0004575, Syn, Synapsin, [RH, Score=321, Expect=2e-98]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=163, Expect=6e-45]} {Smed: dd_Smed_v6_3135_0_1, dd_Smed_v6_3135_0_1, [RH, Score=387, Expect=3e-128]} {RNA1509_58931} {RNA1310_22468.1} {RNA815_2386} |
5. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 3.611 | - | - | 0.858 | 0.971 | 0.826 | 0.956 | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
6. | MligTC455_51009 | 16 | 0.33 | Mlig455_057754 | Neo: - Age: - |
3.519 | - | - | 0.919 | 0.773 | 0.845 | 0.982 | Mlig455_057754 {REF} {Length: 198} {NoTransDecoderORF} | |
7. | MligTC455_40961 | 1390 | 28.96 | Mlig455_055735 | Neo: - Age: Down-Up-Up Region-specific R2: 4.023 Region-enriched R2: 3.902/0.00000 |
3.494 | - | - | 0.906 | 0.911 | 0.726 | 0.951 | Mlig455_055735 {REF} {Length: 782} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.6]} {RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1310_48462, RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1509_12482, RNA1509_45015, RNA1509_52082, RNA815_25160} | |
8. | MligTC455_49925 | 1150 | 23.95 | Mlig455_064457 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.630 Region-enriched R2: 9.768/0.00000 |
3.471 | - | - | 0.846 | 0.716 | 0.953 | 0.956 | Mlig455_064457 {REF} {Length: 2074} {RNA1509_11575, RNA1509_47467, RNA1509_51886, RNA1509_59587} {RNA1310_82147.1, RNA1509_11575, RNA1509_47467, RNA1509_51886, RNA1509_59587} {RNA1509_11575, RNA1509_47467, RNA1509_51886, RNA1509_59587, RNA815_19226.1} | |
9. | MligTC455_48520 | 46 | 0.96 | Mlig455_004433 | Neo: - Age: - |
3.42 | - | - | 0.989 | 0.722 | 0.748 | 0.961 | Mlig455_004433 {REF} {Length: 701} {RNA1310_56623} {RNA815_27009} | |
10. | MligTC455_31696 | 99 | 2.06 | Mlig455_054925 | Neo: - Age: Down-Down-Up |
3.416 | - | - | 0.735 | 0.817 | 0.952 | 0.912 | Mlig455_054925 {REF} {Length: 1987} {RNA1310_24838} {RNA815_18727} | |
11. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
3.395 | - | - | 0.866 | 0.700 | 0.878 | 0.951 | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
12. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 3.353 | - | - | 0.769 | 0.848 | 0.749 | 0.987 | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
13. | MligTC455_14598 | 52 | 1.07 | Mlig455_058970 | Neo: - Age: - |
3.33 | - | - | 0.758 | 0.862 | 0.733 | 0.977 | Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309} | |
14. | MligTC455_40648 | 60 | 1.24 | Mlig455_034479 | Neo: - Age: Down-Up-Up |
3.295 | - | - | 0.768 | 0.972 | 0.838 | 0.717 | Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590} | |
15. | MligTC455_27682 | 3197 | 66.6 | Mlig455_027286 | Neo: - Age: - Region-specific R2: 3.413 Region-enriched R2: 2.922/0.00000 |
3.256 | - | - | 0.785 | 0.744 | 0.961 | 0.766 | Mlig455_027286 {REF} {Length: 782} {RNA1509_13213, RNA1509_17884, RNA1509_19592, RNA1509_20033} {RNA1310_17576.1, RNA1509_13213, RNA1509_17884, RNA1509_19592} {RNA1509_13213, RNA1509_17884, RNA1509_19592, RNA815_6182.1} | |
16. | MligTC455_24108 | 17 | 0.35 | Mlig455_019116 | Neo: - Age: - |
KCNK16 | 2.922 | - | - | 0.994 | - | 0.946 | 0.982 | Mlig455_019116 {REF} {Length: 1389} {Pfam: Ion channel [PF07885.18, score=118.0]; Ion transport protein [PF00520.33, score=29.1]} {Human: ENSG00000095981, KCNK16, potassium two pore domain channel subfamily K member 16, [Score=155, Expect=5e-44]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [RH, Score=141, Expect=3e-37]} {Dmel: FBgn0037690, Task7, TWIK-related acid-sensitive K[+] channel 7, [Score=110, Expect=3e-27]} {Celegans: WBGene00006696, twk-46, TWiK family of potassium channels, [Score=115, Expect=3e-29]} {Smed: dd_Smed_v6_9028_0_1, dd_Smed_v6_9028_0_1, [Score=121, Expect=4e-31]} {RNA1310_125949} |
17. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
2.916 | - | - | 0.989 | 0.945 | - | 0.982 | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
18. | MligTC455_46581 | 31 | 0.64 | Mlig455_042524 | Neo: - Age: - |
2.903 | - | - | 0.947 | 0.975 | 0.981 | - | Mlig455_042524 {REF} {Length: 975} {RNA1509_46101} {RNA1310_32444} {RNA815_42659} | |
19. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
2.888 | - | - | 0.966 | 0.925 | - | 0.997 | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
20. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
2.887 | - | - | 0.995 | 0.938 | - | 0.954 | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
21. | MligTC455_50777 | 40 | 0.83 | Mlig455_042072 | Neo: - Age: - |
MTNR1B | 2.871 | - | - | 0.983 | 0.916 | - | 0.972 | Mlig455_042072 {REF} {Length: 2881} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.0]; Olfactory receptor [PF13853.8, score=24.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]} {Human: ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=94.4, Expect=2e-21]; ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=90.1, Expect=5e-20]} {Mouse: ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=94.0, Expect=2e-21]; ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=89.4, Expect=6e-20]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=57.0, Expect=7e-09]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_19535_0_1, dd_Smed_v6_19535_0_1, [Score=95.5, Expect=2e-22]} {RNA1310_66047} {RNA815_34066} |
22. | MligTC455_48757 | 61 | 1.28 | Mlig455_008828, Mlig455_008932 | Neo: - Age: Up-Down-Up |
DDC | 2.853 | - | - | 0.971 | 0.912 | 0.970 | - | Mlig455_008828 {REF} {Length: 2057} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=471.9]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=572, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=558, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=553, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_37174} {RNA815_42090} Mlig455_008932 {REF} {Length: 2145} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=470.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=574, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=559, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=554, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=564, Expect=0.0]} {RNA1310_37174} {RNA815_42090} |
23. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 2.85 | - | - | 0.898 | 0.961 | - | 0.991 | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
24. | MligTC455_45666 | 652 | 13.58 | Mlig455_013011, Mlig455_013040 | Neo: - Age: Up-Down-Up Region-specific R2: 4.509 Region-enriched R2: 3.140/0.01108 |
2.846 | - | - | 0.983 | 0.882 | - | 0.981 | Mlig455_013011 {REF} {Length: 1193} {RNA1509_13068} {RNA1310_46610} {RNA815_23273} Mlig455_013040 {REF} {Length: 923} {RNA1509_13068} {RNA1310_46610, RNA1509_13068} {RNA1509_13068, RNA815_23273} |
|
25. | MligTC455_50778 | 36 | 0.76 | Mlig455_042296 | Neo: - Age: - |
GPR50 | 2.846 | - | - | 0.964 | 0.902 | - | 0.980 | Mlig455_042296 {REF} {Length: 1415} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=40.0]; Olfactory receptor [PF13853.8, score=34.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.9]} {Human: ENSG00000102195, GPR50, G protein-coupled receptor 50, [Score=124, Expect=4e-31]; ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=119, Expect=2e-30]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=120, Expect=4e-31]; ENSMUSG00000056380, Gpr50, G-protein-coupled receptor 50, [Score=119, Expect=2e-29]; ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=118, Expect=5e-30]} {Dmel: FBgn0038980, Octbeta1R, Octopamine beta1 receptor, [Score=92.0, Expect=1e-20]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=84.7, Expect=1e-18]} {RNA1310_66047} {RNA815_34066} |
26. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 2.83 | - | - | - | 0.968 | 0.871 | 0.991 | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
27. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 2.823 | - | - | 0.963 | 0.899 | - | 0.961 | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
28. | MligTC455_08774 | 25 | 0.53 | Mlig455_001889 | Neo: - Age: Up-Down-Down |
HCRTR2 | 2.817 | - | - | 0.995 | - | 0.849 | 0.973 | Mlig455_001889 {REF} {Length: 3436} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=160.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=24.1]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=215, Expect=2e-63]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [RH, Score=212, Expect=1e-62]} {Dmel: FBgn0038874, ETHR, [Score=142, Expect=6e-37]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=116, Expect=6e-28]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=202, Expect=1e-59]} {RNA1310_31833} {RNA815_15909} |
29. | MligTC455_31370 | 27 | 0.55 | Mlig455_035805 | Neo: - Age: - |
ASIC1 | 2.813 | - | - | 0.946 | 0.873 | - | 0.994 | Mlig455_035805 {REF} {Length: 3035} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=60.1, Expect=8e-09]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_16346_0_1, dd_Smed_v6_16346_0_1, [Score=107, Expect=3e-24]} {RNA1310_49983} {RNA815_25991} |
30. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 2.797 | - | - | 0.988 | 0.813 | - | 0.996 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
31. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
2.793 | - | - | 0.977 | 0.836 | - | 0.980 | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
32. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 2.784 | - | - | 0.879 | 0.919 | - | 0.986 | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
33. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
2.777 | - | - | 0.945 | 0.868 | - | 0.964 | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
34. | MligTC455_48218 | 1632 | 34 | Mlig455_054782, Mlig455_054874 | Neo: - Age: Down-Down-Up Region-specific R2: 3.792 Region-enriched R2: 2.673/0.00000 Regeneration-downregulated BL: -2.255 Regeneration-depleted BL: -2.255 |
2.775 | - | - | 0.965 | 0.890 | - | 0.920 | Mlig455_054782 {REF} {Length: 1928} {RNA1509_16585} {RNA1310_35143} {RNA815_1375.1} Mlig455_054874 {REF} {Length: 2445} {RNA1509_16585} {RNA1310_35143, RNA1509_16585} {RNA1509_16585, RNA815_1375.1} |
|
35. | MligTC455_10151 | 146 | 3.05 | Mlig455_068692, Mlig455_068719 | Neo: - Age: - |
KREMEN1 | 2.769 | - | - | 0.944 | 0.862 | - | 0.963 | Mlig455_068692 {REF} {Length: 1086} {Pfam: WSC domain [PF01822.21, score=56.5]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.4, Expect=7e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=68.9, Expect=2e-14]} {RNA1310_42686} {RNA815_25047} Mlig455_068719 {REF} {Length: 1973} {TRANSSPLICED} {Pfam: WSC domain [PF01822.21, score=55.8]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.1, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=67.0, Expect=8e-14]} {RNA1509_56630} {RNA1310_42686} {RNA815_25047} |
36. | MligTC455_19304 | 36 | 0.76 | Mlig455_036451 | Neo: - Age: - |
2.766 | - | - | 0.960 | 0.967 | 0.839 | - | Mlig455_036451 {REF} {Length: 1603} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [RH, Score=266, Expect=8e-87]} {RNA1310_117429} | |
37. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 2.765 | - | - | 0.915 | 0.857 | - | 0.993 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
38. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
2.765 | - | - | 0.959 | 0.840 | - | 0.966 | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
39. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 2.748 | - | - | 0.960 | 0.802 | - | 0.986 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
40. | MligTC455_43750 | 799 | 16.65 | Mlig455_060601, Mlig455_060642 | Neo: - Age: logFC(26M/2M)=0.548 Region-specific R2: 5.695 Region-enriched R2: 4.415/0.00001 |
2.742 | - | - | 0.871 | 0.881 | 0.990 | - | Mlig455_060601 {REF} {Length: 722} {RNA1509_23811, RNA1509_48787} {RNA1310_60850, RNA1509_23811, RNA1509_48787} {RNA1509_23811, RNA1509_48787, RNA815_31279} Mlig455_060642 {REF} {Length: 646} {RNA1509_23811} {RNA1310_60850} {RNA815_31279} |
|
41. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 2.737 | - | - | 0.922 | 0.819 | - | 0.996 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
42. | MligTC455_19248 | 238 | 4.95 | Mlig455_036051 | Neo: - Age: - Region-enriched R2: 8.870/0.00000 |
2.734 | - | - | 0.940 | - | 0.798 | 0.996 | Mlig455_036051 {REF} {Length: 807} {RNA1509_57448} {RNA1310_51394} {RNA815_26076} | |
43. | MligTC455_36372 | 925 | 19.28 | Mlig455_005680 | Neo: - Age: logFC(26M/2M)=2.101 Region-enriched R2: 7.233/0.00006 |
2.732 | - | - | 0.907 | 0.832 | 0.993 | - | Mlig455_005680 {REF} {Length: 1993} {RNA1509_18409, RNA1509_31432} {RNA1310_82233, RNA1509_18409, RNA1509_31432} {RNA1509_18409, RNA1509_31432, RNA815_42934} | |
44. | MligTC455_09224 | 21 | 0.43 | Mlig455_038078 | Neo: - Age: - |
2.728 | - | - | 0.835 | 0.908 | - | 0.985 | Mlig455_038078 {REF} {Length: 771} {Pfam: PAN domain [PF00024.28, score=28.0]} {RNA1509_46267} {RNA1310_51656} {RNA815_32275.1} | |
45. | MligTC455_34655 | 89 | 1.86 | Mlig455_058020, Mlig455_058176 | Neo: - Age: - Region-enriched R2: 5.798/0.00826 |
PPEF1 | 2.723 | - | - | 0.990 | 0.819 | - | 0.914 | Mlig455_058020 {REF} {Length: 3007} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=84.9]; EF-hand domain pair [PF13499.8, score=77.8]; EF hand [PF00036.34, score=66.0]; EF-hand domain pair [PF13833.8, score=52.1]; EF-hand domain [PF13405.8, score=48.4]; EF hand [PF13202.8, score=38.2]; PPP5 TPR repeat region [PF08321.14, score=37.0]; EF-hand domain [PF14658.8, score=23.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.4]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=416, Expect=2e-138]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=413, Expect=9e-138]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=404, Expect=3e-134]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=455, Expect=2e-155]} {Smed: dd_Smed_v6_11874_0_2, dd_Smed_v6_11874_0_2, [Score=516, Expect=2e-178]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} Mlig455_058176 {REF} {Length: 3371} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=102.6]; EF-hand domain pair [PF13499.8, score=72.6]; EF hand [PF00036.34, score=64.2]; EF-hand domain pair [PF13833.8, score=51.3]; EF-hand domain [PF13405.8, score=46.1]; EF hand [PF13202.8, score=36.7]; PPP5 TPR repeat region [PF08321.14, score=36.6]; EF-hand domain [PF14658.8, score=26.5]; IQ calmodulin-binding motif [PF00612.29, score=21.3]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.8]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=520, Expect=3e-177]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=529, Expect=2e-180]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=598, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=671, Expect=0.0]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} |
46. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
2.722 | - | - | 0.971 | 0.783 | - | 0.968 | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
47. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.715 | - | - | 0.951 | 0.767 | - | 0.997 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
48. | MligTC455_15586 | 179 | 3.72 | Mlig455_061074 | Neo: - Age: - Region-enriched R2: 6.557/0.00000 |
2.714 | - | - | 0.971 | 0.864 | - | 0.879 | Mlig455_061074 {REF} {Length: 997} {Dmel: FBgn0013467, igl, igloo, [Score=43.5, Expect=3e-06]} {Smed: dd_Smed_v6_4783_0_82, dd_Smed_v6_4783_0_82, [Score=70.1, Expect=6e-16]} {RNA1509_36803} {RNA1310_35463} {RNA815_8499} | |
49. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 2.711 | - | - | 0.856 | 0.873 | - | 0.982 | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
50. | MligTC455_16329 | 1019 | 21.23 | Mlig455_007993 | Neo: - Age: - Region-specific R2: 3.685 Region-enriched R2: 3.576/0.00000 |
2.708 | - | - | 0.965 | 0.911 | - | 0.832 | Mlig455_007993 {REF} {Length: 635} {RNA1509_22236} {RNA1310_84275, RNA1509_22236} {RNA1509_22236, RNA815_43046} | |
51. | MligTC455_20953 | 115 | 2.4 | Mlig455_002904 | Neo: - Age: - Region-enriched R2: 5.041/0.00953 |
2.706 | - | - | 0.902 | 0.844 | - | 0.960 | Mlig455_002904 {REF} {Length: 1514} {RNA1310_19276} {RNA815_20827} | |
52. | MligTC455_46691 | 41 | 0.85 | Mlig455_018781, Mlig455_018951 | Neo: - Age: Up-Down-Down |
2.7 | - | - | 0.884 | - | 0.845 | 0.971 | Mlig455_018781 {REF} {Length: 1694} {Celegans: WBGene00021142, clec-133, C-type LECtin, [RH, Score=52.0, Expect=6e-08]} {RNA1310_43489} {RNA815_41340} Mlig455_018951 {REF} {Length: 2466} {Celegans: WBGene00021142, clec-133, C-type LECtin, [RH, Score=52.0, Expect=6e-08]} {RNA1310_38733.1} {RNA815_41340} |
|
53. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
2.695 | - | - | 0.986 | 0.725 | - | 0.984 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
54. | MligTC455_45622 | 647 | 13.48 | Mlig455_069391 | Neo: - Age: - Region-specific R2: 5.132 Region-enriched R2: 3.915/0.00000 Regeneration-downregulated R2: -2.412 Regeneration-depleted R2: -2.412 |
2.693 | - | - | 0.792 | 0.937 | - | 0.964 | Mlig455_069391 {REF} {Length: 971} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982} {RNA1310_46295} {RNA815_23543} | |
55. | MligTC455_36371 | 1892 | 39.41 | Mlig455_005636 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.119/0.00007 |
C6orf120 | 2.691 | - | - | 0.914 | 0.815 | 0.962 | - | Mlig455_005636 {REF} {Length: 4589} {TRANSSPLICED} {Pfam: Putative cytokine, C6ORF120 [PF17065.7, score=46.3]} {Human: ENSG00000185127, C6orf120, chromosome 6 open reading frame 120, [Score=52.8, Expect=5e-08]} {Mouse: ENSMUSG00000050088, 1600012H06Rik, RIKEN cDNA 1600012H06 gene, [Score=52.4, Expect=5e-08]} {RNA1509_33302, RNA1509_46654} {RNA1310_15958, RNA1509_46654} {RNA1509_46654, RNA815_10779} |
56. | MligTC455_19410 | 194 | 4.04 | Mlig455_047838 | Neo: - Age: Down-Up-Up Region-specific R2: 5.170 Region-enriched R2: 5.689/0.00000 |
2.689 | - | - | 0.964 | 0.785 | - | 0.940 | Mlig455_047838 {REF} {Length: 724} {TRANSSPLICED} {RNA1509_54915} {RNA1310_53549} {RNA815_27051} | |
57. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
2.689 | - | - | 0.993 | 0.749 | - | 0.947 | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
58. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 2.689 | - | - | 0.830 | 0.909 | - | 0.950 | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
59. | MligTC455_43602 | 1418 | 29.54 | Mlig455_053986 | Neo: - Age: - Region-specific R2: 4.626 Region-enriched R2: 3.844/0.00000 Regeneration-downregulated R2: -2.432 Regeneration-depleted R2: -2.432 |
2.688 | - | - | 0.983 | 0.742 | - | 0.963 | Mlig455_053986 {REF} {Length: 2161} {RNA1509_15576} {RNA1310_12096.1} {RNA815_32931} | |
60. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 2.685 | - | - | 0.973 | - | 0.713 | 0.999 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
61. | MligTC455_50171 | 151 | 3.14 | Mlig455_065462 | Neo: - Age: logFC(26M/2M)=0.548 Region-specific R2: 5.212 Region-enriched R2: 5.063/0.00089 Regeneration-downregulated R2: -2.783 Regeneration-depleted R2: -2.783 |
SCNN1A | 2.684 | - | - | 0.912 | 0.822 | - | 0.950 | Mlig455_065462 {REF} {Length: 3905} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=67.0, Expect=5e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=92.8, Expect=1e-19]} {Smed: dd_Smed_v6_16959_0_1, dd_Smed_v6_16959_0_1, [Score=275, Expect=3e-83]} {RNA1509_60030} {RNA1310_56761} {RNA815_31877.1} |
62. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 2.679 | - | - | 0.877 | 0.977 | - | 0.825 | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
63. | MligTC455_51763 | 1421 | 29.6 | Mlig455_015843 | Neo: - Age: - Region-specific R2: 3.066 Region-enriched R2: 2.560/0.00003 |
2.675 | - | - | 0.806 | 0.965 | - | 0.904 | Mlig455_015843 {REF} {Length: 805} {RNA1509_26419, RNA1509_39553, RNA1509_39658} {RNA1310_60107.2, RNA1509_26419, RNA1509_39553, RNA1509_39658} {RNA1509_26419, RNA1509_39553, RNA1509_39658, RNA815_31573} | |
64. | MligTC455_14752 | 17 | 0.36 | Mlig455_009102 | Neo: - Age: - |
2.674 | - | - | 0.801 | 0.900 | 0.973 | - | Mlig455_009102 {REF} {Length: 1690} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=50.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=89.7, Expect=1e-19]} {RNA1509_4484} {RNA1310_25467} {RNA815_39314} | |
65. | MligTC455_43676 | 56 | 1.16 | Mlig455_058053, Mlig455_058096 | Neo: - Age: - |
2.67 | - | - | 0.723 | 0.966 | 0.981 | - | Mlig455_058053 {REF} {Length: 391} {NoTransDecoderORF} {RNA1509_25254} {RNA1310_102705} {RNA815_52459} Mlig455_058096 {REF} {Length: 1983} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=90.1, Expect=1e-19]} {RNA1509_1472} {RNA1310_25467} {RNA815_39314} |
|
66. | MligTC455_46886 | 51 | 1.05 | Mlig455_015258 | Neo: - Age: - Region-enriched R2: 4.468/0.04690 |
PRKG2 | 2.67 | - | - | 0.971 | 0.880 | - | 0.819 | Mlig455_015258 {REF} {Length: 3110} {Pfam: Protein kinase domain [PF00069.27, score=225.4]; Cyclic nucleotide-binding domain [PF00027.31, score=118.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=117.9]; Kinase-like [PF14531.8, score=25.3]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=668, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=669, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=683, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=667, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=672, Expect=0.0]} {RNA1509_26653} {RNA1310_15330.1} {RNA815_26005} |
67. | MligTC455_45769 | 79 | 1.65 | Mlig455_018116 | Neo: - Age: - |
2.666 | - | - | 0.929 | - | 0.752 | 0.985 | Mlig455_018116 {REF} {Length: 3312} {Pfam: NACHT domain [PF05729.14, score=33.6]; AAA ATPase domain [PF13191.8, score=25.1]; AAA domain [PF13401.8, score=19.4]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [Score=138, Expect=2e-33]} {RNA1509_44893} {RNA1310_38241} {RNA815_33748} | |
68. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 2.665 | - | - | 0.991 | 0.723 | - | 0.951 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
69. | MligTC455_13375 | 48 | 1 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
2.664 | - | - | 0.782 | 0.906 | - | 0.976 | Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} | |
70. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
2.659 | - | - | 0.953 | 0.744 | - | 0.962 | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
71. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
2.659 | - | - | 0.985 | 0.854 | - | 0.820 | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
72. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 2.658 | - | - | 0.962 | 0.740 | - | 0.956 | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
73. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
2.651 | - | - | 0.927 | 0.742 | - | 0.982 | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
74. | MligTC455_26243 | 7282 | 151.7 | Mlig455_058373 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.861 Region-enriched R2: 2.532/0.00002 |
PPIB | 2.648 | - | - | - | 0.827 | 0.951 | 0.870 | Mlig455_058373 {REF} {Length: 1101} {Pfam: Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD [PF00160.23, score=123.3]} {Human: ENSG00000166794, PPIB, peptidylprolyl isomerase B, [Score=154, Expect=2e-47]} {Mouse: ENSMUSG00000032383, Ppib, peptidylprolyl isomerase B, [Score=153, Expect=4e-47]} {Dmel: FBgn0034753, CG2852, [Score=131, Expect=6e-39]} {Celegans: WBGene00000882, cyn-6, Peptidyl-prolyl cis-trans isomerase 6, [Score=139, Expect=4e-42]} {Smed: dd_Smed_v6_348_0_1, dd_Smed_v6_348_0_1, [Score=233, Expect=6e-79]} {RNA1509_11405, RNA1509_2163} {RNA1310_10180, RNA1509_11405} {RNA1509_11405, RNA815_2338.1} |
75. | MligTC455_25382 | 4668 | 97.26 | Mlig455_000103, Mlig455_063773 | Neo: - Age: - Region-specific R2: 3.508 Region-enriched R2: 3.123/0.00000 |
2.641 | - | - | 0.806 | 0.969 | 0.866 | - | Mlig455_000103 {REF} {Length: 990} {RNA1509_36813} {RNA1310_39295, RNA1509_36813} {RNA1509_36813, RNA815_13177} Mlig455_063773 {REF} {Length: 890} {RNA1509_6028} {RNA1310_39295} {RNA815_13177} |
|
76. | MligTC455_38699 | 267 | 5.56 | Mlig455_054929 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.183/0.01222 |
COLEC10 | 2.64 | - | - | 0.964 | 0.787 | 0.889 | - | Mlig455_054929 {REF} {Length: 1403} {Pfam: Lectin C-type domain [PF00059.23, score=45.4]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
77. | MligTC455_14126 | 1888 | 39.32 | Mlig455_031057 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-1.763 Region-specific R2: 6.685 Region-enriched R2: 8.246/0.00000 Regeneration-downregulated R2: -3.933 Regeneration-depleted R2: -3.933 |
SSPO | 2.633 | - | - | 0.777 | 0.897 | 0.959 | - | Mlig455_031057 {REF} {Length: 3178} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=118.7]; Thrombospondin type 1 domain [PF00090.21, score=76.9]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=46.2]; CCN3 Nov like TSP1 domain [PF19035.2, score=19.7]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=113, Expect=9e-25]} {Dmel: FBgn0026721, fat-spondin, [Score=65.5, Expect=2e-10]} {Celegans: WBGene00006893, spon-1, SPONdin (Extracellular matrix glycoprotein) family, [Score=74.3, Expect=3e-13]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [RH, Score=487, Expect=3e-156]} {RNA1509_2451} {RNA1310_3554.1} {RNA815_1109} |
78. | MligTC455_53240 | 1601 | 33.35 | Mlig455_025555 | Neo: - Age: - Region-specific R2: 4.178 Region-enriched R2: 2.883/0.00000 |
2.632 | - | - | 0.902 | 0.762 | - | 0.968 | Mlig455_025555 {REF} {Length: 2163} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=69.7, Expect=2e-14]} {Celegans: WBGene00010290, F58H1.7, [Score=64.7, Expect=4e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=168, Expect=3e-53]} {RNA1509_58542} {RNA1310_40950, RNA1509_58542} {RNA1509_58542, RNA815_19778.1} | |
79. | MligTC455_53239 | 733 | 15.27 | Mlig455_025537 | Neo: - Age: - Region-specific R2: 4.434 Region-enriched R2: 3.108/0.00000 |
2.631 | - | - | 0.909 | 0.766 | - | 0.956 | Mlig455_025537 {REF} {Length: 964} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=70.9, Expect=5e-15]} {Celegans: WBGene00010290, F58H1.7, [Score=63.9, Expect=8e-13]} {Smed: dd_Smed_v6_5576_0_1, dd_Smed_v6_5576_0_1, [RH, Score=168, Expect=2e-53]} {RNA1509_58542} {RNA1310_40950} {RNA815_19778.1} | |
80. | MligTC455_49862 | 26 | 0.54 | Mlig455_019435 | Neo: - Age: - |
SHOX2 | 2.63 | - | - | - | 0.948 | 0.730 | 0.952 | Mlig455_019435 {REF} {Length: 904} {Pfam: Homeodomain [PF00046.31, score=84.8]; Homeobox KN domain [PF05920.13, score=23.6]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=89.0, Expect=4e-22]; ENSG00000185960, SHOX, short stature homeobox, [Score=87.0, Expect=5e-21]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=89.0, Expect=3e-22]} {Dmel: FBgn0085396, CG34367, [Score=89.7, Expect=9e-22]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=83.6, Expect=5e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=86.3, Expect=2e-20]} {RNA1310_51707} {RNA815_41055} |
81. | MligTC455_36373 | 2360 | 49.17 | Mlig455_008690 | Neo: - Age: - Region-enriched R2: 7.147/0.00000 |
2.628 | - | - | 0.835 | 0.820 | 0.973 | - | Mlig455_008690 {REF} {Length: 1552} {RNA1509_2189} {RNA1310_71597} {RNA815_31926.1} | |
82. | MligTC455_14125 | 432 | 9.01 | Mlig455_031050 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.941 Region-specific R2: 7.318 Region-enriched R2: 7.339/0.00000 |
OTOG | 2.627 | - | - | 0.771 | 0.896 | 0.960 | - | Mlig455_031050 {REF} {Length: 2951} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=32.8]; Pacifastin inhibitor (LCMII) [PF05375.15, score=25.4]} {Human: ENSG00000188162, OTOG, otogelin, [Score=49.3, Expect=6e-06]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=53.9, Expect=1e-07]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=117, Expect=3e-29]} {RNA1509_2451} {RNA1310_3554.1} {RNA815_1109} |
83. | MligTC455_41130 | 1186 | 24.72 | Mlig455_000166, Mlig455_000179, Mlig455_067712 | Neo: - Age: Down-Up-Down Region-specific R2: 5.626 Region-enriched R2: 4.906/0.00009 Regeneration-downregulated R3: -5.200 Regeneration-depleted R3: -5.200 |
2.627 | - | - | 0.859 | 0.787 | - | 0.981 | Mlig455_000166 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_000179 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_067712 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} |
|
84. | MligTC455_46188 | 25 | 0.51 | Mlig455_039664, Mlig455_039727 | Neo: - Age: - |
2.626 | - | - | 0.844 | - | 0.800 | 0.982 | Mlig455_039664 {REF} {Length: 1353} Mlig455_039727 {REF} {Length: 1348} |
|
85. | MligTC455_28560 | 6060 | 126.24 | Mlig455_028251 | Neo: - Age: - Region-specific R2: 2.839 Region-enriched R2: 1.867/0.00000 Regeneration-depleted BL: -1.887 |
SYT11 | 2.622 | - | - | 0.963 | 0.741 | - | 0.918 | Mlig455_028251 {REF} {Length: 2851} {Pfam: C2 domain [PF00168.32, score=161.3]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=304, Expect=1e-99]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=305, Expect=3e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=353, Expect=3e-118]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=233, Expect=4e-73]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=397, Expect=6e-137]} {RNA1509_17703, RNA1509_303, RNA1509_58747} {RNA1310_7615, RNA1509_17703, RNA1509_58747} {RNA1509_17703, RNA1509_58747, RNA815_4825} |
86. | MligTC455_28559 | 6127 | 127.65 | Mlig455_028180 | Neo: - Age: - Region-specific R2: 2.829 Region-enriched R2: 1.854/0.00000 Regeneration-depleted BL: -1.839 |
SYT11 | 2.618 | - | - | 0.961 | 0.739 | - | 0.918 | Mlig455_028180 {REF} {Length: 2785} {Pfam: C2 domain [PF00168.32, score=161.4]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=305, Expect=7e-100]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=306, Expect=2e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=351, Expect=1e-117]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=232, Expect=2e-72]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=399, Expect=2e-137]} {RNA1509_303} {RNA1310_7615, RNA1509_303} {RNA1509_303, RNA815_4825} |
87. | MligTC455_17039 | 24 | 0.5 | Mlig455_025016 | Neo: - Age: - |
2.617 | - | - | 0.756 | 0.896 | 0.965 | - | Mlig455_025016 {REF} {Length: 2009} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.8]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [RH, Score=209, Expect=1e-63]} {RNA1310_42205} {RNA815_15017} | |
88. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
2.616 | - | - | 0.953 | 0.762 | - | 0.901 | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} | |
89. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 2.615 | - | - | 0.877 | 0.753 | - | 0.985 | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
90. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 2.611 | - | - | 0.932 | 0.701 | - | 0.978 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
91. | MligTC455_52164 | 49 | 1.01 | Mlig455_019248 | Neo: - Age: Down-Up-Up Region-enriched R1: 12.972/0.02781 |
2.608 | - | - | - | 0.774 | 0.882 | 0.952 | Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298} | |
92. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 2.605 | - | - | - | 0.977 | 0.752 | 0.876 | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
93. | MligTC455_35583 | 48 | 0.99 | Mlig455_009953 | Neo: - Age: - |
2.602 | - | - | 0.897 | 0.732 | - | 0.973 | Mlig455_009953 {REF} {Length: 919} {Pfam: Lectin C-type domain [PF00059.23, score=25.9]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=61.6, Expect=2e-11]} {RNA1509_20946} {RNA1310_71370} {RNA815_4785.4} | |
94. | MligTC455_33703 | 69 | 1.44 | Mlig455_002442 | Neo: - Age: - |
2.601 | - | - | 0.953 | 0.738 | - | 0.910 | Mlig455_002442 {REF} {Length: 1320} {NoTransDecoderORF} {RNA1310_44761} {RNA815_22052} | |
95. | MligTC455_37989 | 83 | 1.72 | Mlig455_018192 | Neo: - Age: - |
2.6 | - | - | 0.812 | 0.955 | 0.833 | - | Mlig455_018192 {REF} {Length: 1275} {Pfam: EF-hand domain pair [PF13499.8, score=36.8]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.5]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=105, Expect=6e-27]} {RNA1310_31713.1} {RNA815_36423} | |
96. | MligTC455_12388 | 25 | 0.52 | Mlig455_000936 | Neo: - Age: - |
SETMAR | 2.597 | - | - | 0.751 | 0.864 | 0.982 | - | Mlig455_000936 {REF} {Length: 2242} {Pfam: Transposase (partial DDE domain) [PF01359.20, score=48.4]; DDE superfamily endonuclease [PF13358.8, score=29.0]; Homeodomain-like domain [PF13565.8, score=24.2]; Transposase [PF01498.20, score=21.1]; Winged helix-turn helix [PF13551.8, score=19.9]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=167, Expect=3e-45]} {Smed: dd_Smed_v6_52102_0_1, dd_Smed_v6_52102_0_1, [Score=69.7, Expect=1e-14]} {RNA1310_28836.1} {RNA815_34045} |
97. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 2.592 | - | - | - | 0.799 | 0.797 | 0.996 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
98. | MligTC455_49863 | 62 | 1.29 | Mlig455_019320, Mlig455_019542 | Neo: - Age: - |
SHOX2 | 2.592 | - | - | 0.955 | 0.795 | - | 0.842 | Mlig455_019320 {REF} {Length: 1251} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.2, Expect=5e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=7e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.2, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=84.0, Expect=2e-19]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} Mlig455_019542 {REF} {Length: 1249} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.6, Expect=4e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=6e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.6, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=86.7, Expect=3e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} |
99. | MligTC455_11713 | 8 | 0.16 | Mlig455_030060 | Neo: - Age: - |
2.592 | - | - | 0.767 | 0.980 | 0.845 | - | Mlig455_030060 {REF} {Length: 1189} {RNA1310_40798} {RNA815_26160} | |
100. | MligTC455_26004 | 161 | 3.34 | Mlig455_005523, Mlig455_036228 | Neo: - Age: logFC(26M/2M)=0.483 Region-enriched R2: 3.880/0.02863 |
2.586 | - | - | 0.894 | 0.984 | - | 0.708 | Mlig455_005523 {REF} {Length: 3106} {RNA1509_54312} {RNA1310_125315} {RNA815_31978} Mlig455_036228 {REF} {Length: 3817} {RNA1509_54312} {RNA1310_75243} {RNA815_31978} |